Scarica l'app Stockscreener
0.5117
4.37%
-0.0234
Precedente Chiudi:
$0.5351
Aprire:
$0.543
Volume 24 ore:
420.25K
Relative Volume:
0.51
Capitalizzazione di mercato:
$28.40M
Reddito:
-
Utile/perdita netta:
$-20.23M
Rapporto P/E:
-0.9108
EPS:
-0.5618
Flusso di cassa netto:
$-13.97M
1 W Prestazione:
-8.46%
1M Prestazione:
-26.18%
6M Prestazione:
-71.73%
1 anno Prestazione:
-60.02%
Intervallo 1D:
$0.5019
$0.543
Intervallo di 1 settimana:
$0.5019
$0.619
Portata 52W:
$0.5019
$4.00
Heartbeam Inc Stock (BEAT) Company Profile
Nome
Heartbeam Inc
Settore
Industria
Telefono
408-899-4443
Indirizzo
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT vs VEEV, BTSG, HQY, TEM, TXG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
0.5117 | 28.40M | 0 | -20.23M | -13.97M | -0.5618 |
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-20 | Downgrade | D. Boral Capital | Buy → Hold |
| 2026-03-31 | Iniziato | B. Riley Securities | Buy |
| 2026-03-27 | Iniziato | D. Boral Capital | Buy |
| 2026-03-16 | Downgrade | The Benchmark Company | Buy → Speculative Buy |
| 2025-12-11 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2025-12-08 | Iniziato | H.C. Wainwright | Buy |
| 2025-10-31 | Iniziato | Roth Capital | Buy |
| 2020-09-11 | Iniziato | Needham | Buy |
| 2020-09-02 | Iniziato | Robert W. Baird | Neutral |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-08-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | Reiterato | Dougherty & Company | Buy |
| 2018-07-26 | Reiterato | Lake Street | Buy |
| 2018-04-26 | Reiterato | The Benchmark Company | Buy |
| 2018-02-23 | Reiterato | Dougherty & Company | Buy |
| 2017-11-08 | Reiterato | Dougherty & Company | Buy |
| 2017-10-26 | Iniziato | Raymond James | Outperform |
| 2017-10-24 | Iniziato | SunTrust | Buy |
| 2017-08-09 | Reiterato | Dougherty & Company | Buy |
| 2017-07-19 | Reiterato | The Benchmark Company | Buy |
| 2017-04-11 | Reiterato | Dougherty & Company | Buy |
| 2016-12-02 | Iniziato | Dougherty & Company | Buy |
| 2016-09-13 | Iniziato | Sidoti | Buy |
| 2016-08-03 | Reiterato | The Benchmark Company | Buy |
| 2015-07-28 | Reiterato | Dougherty & Company | Buy |
| 2013-10-24 | Iniziato | The Benchmark Company | Buy |
| 2013-08-21 | Iniziato | Dougherty & Company | Buy |
Mostra tutto
Heartbeam Inc Borsa (BEAT) Ultime notizie
Form 4 Heartbeam Inc For: 25 July By Investing.com - Investing.com South Africa
HeartBeam (NASDAQ: BEAT) CTO receives 105,740 shares in bonus grant - Stock Titan
HeartBeam, Inc. (BEAT) awards 167,760 RSUs to CFO as 2025 bonus - Stock Titan
HeartBeam, Inc. (BEAT) Grants 2,800,000 PRSUs and RSUs to President - Stock Titan
Heartbeam, Inc. (BEAT) Q3 2022 Earnings ReportResults, Call & Slides - TipRanks
Heartbeam, Inc. (BEAT) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Heartbeam, Inc. (BEAT) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Heartbeam, Inc. (BEAT) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now - The Globe and Mail
Stock Ratings | HC Wainwright lowered its price target for NervGen Pharma (NGEN) to $15, with a potential upside of 762.07%; KeyBanc raised its price target for Nvidia (NVDA) to $330 - Sahm
BEAT Initiated Coverage by Maxim Group -- Price Target Announced at $2.00 - GuruFocus
HeartBeam receives patent for multi-modal cardiac sensing device - Investing.com UK
HeartBeam receives patent for multi-modal cardiac sensing device By Investing.com - Investing.com Nigeria
HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device - Business Wire
Heartbeam Inc. (BEAT) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Heartbeam Inc. Warrant (BEATW) Surges 16.61% as Penny Stock Tests Key LevelEarnings Sentiment - dars.gov.et
HeartBeam (BEAT) upgraded to buy: Here's what you should know - MSN
HeartBeam Receives Nasdaq Notice on Minimum Bid Price - TipRanks
HeartBeam Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq warns HeartBeam (NASDAQ: BEAT) over $1 minimum bid price rule - Stock Titan
Heartbeam, Inc. Warrant 2021-31.10.26 on HeartBeam Financial Disclosures & SEC Filings - TradingView
Heartbeam Inc. Warrant (BEATW) Edges Higher at $0.03 Amid Narrow Trading RangeDynamic Hedging - dars.gov.et
Heartbeam Inc. (BEAT) Dips 2.8% as Shares Test Near Support LevelsProfitability Factor - dars.gov.et
HeartBeam (BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital - Yahoo Finance
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule - Business Wire
HeartBeam (NASDAQ: BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital - TradingView
Heartbeam Inc. (BEAT) Q1 2026 Earnings: EPS Beat on Narrower Loss, Pre-Revenue Stage RemainsConsensus Miss Rate - dars.gov.et
HeartBeam (BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study - NewMediaWire
HeartBeam (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study - USA Today
HeartBeam (BEAT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $BEAT - MarketBeat
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study - marketscreener.com
HeartBeam completes enrollment in heart attack detection study - Investing.com
Heartbeam Inc. (BEAT) Q1 2026 Earnings: EPS Surprise Beats Estimates, Stock Declines on Lack of Revenue DetailsProfit Warning Alert - dars.gov.et
HeartBeam (BEAT) Completes Enrollment in Heart Attack Detection Study Ahead of Schedule - GuruFocus
HeartBeam completes enrollment in heart attack detection study By Investing.com - Investing.com Nigeria
Heartbeam Inc. (BEAT) Slips 3.8% as Shares Test Key Support LevelsBeta Neutral Pair - dars.gov.et
Certain Restricted Stock Units of HeartBeam, Inc. are subject to a Lock-Up Agreement Ending on 29-JUN-2026. - marketscreener.com
Certain Warrants of HeartBeam, Inc. are subject to a Lock-Up Agreement Ending on 29-JUN-2026. - marketscreener.com
BEATW Warrants Hold at $0.03: Stalemate Persists for Heartbeam Inc. WarrantsInvestment Factor - dars.gov.et
HeartBeam (BEAT) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Slower Ramp - Yahoo Finance
Price to book forward of Heartbeam, Inc. – NASDAQ:BEAT - TradingView
Enterprise value to revenue forward of Heartbeam, Inc. – NASDAQ:BEAT - TradingView
Price to sales forward of Heartbeam, Inc. – NASDAQ:BEAT - TradingView
HeartBeam (BEAT) Reorganizes to Accelerate Global Commercialization Strategy - NewMediaWire
HeartBeam Reorganizes to Accelerate Global Commercialization of Cardiac Monitoring Technology - MEXC
HeartBeam (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy - TradingView
HeartBeam, Inc. Actuals & Estimates (NASDAQ:BEAT) - TradingView
BEAT Forecast — Price Target — Prediction for 2027 - TradingView
HeartBeam CEO Robert Eno to Step Down; Founder Branislav Vajdic to Lead Operations - Moomoo
HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition - 01net
HeartBeam restructures to license 3D ECG technology - TipRanks
Heartbeam Inc Azioni (BEAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.99%
2.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):